INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 298 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $7,592,866 | +89852.2% | 217,623 | +44.3% | 0.23% | -15.9% |
Q3 2022 | $8,441 | -0.8% | 150,835 | -8.2% | 0.28% | -4.8% |
Q2 2022 | $8,506 | +26.4% | 164,345 | +77.5% | 0.29% | +73.7% |
Q1 2022 | $6,730 | -50.8% | 92,609 | -20.0% | 0.17% | -40.8% |
Q4 2021 | $13,690 | -45.4% | 115,783 | -38.1% | 0.28% | -40.8% |
Q3 2021 | $25,084 | -31.4% | 186,985 | -17.2% | 0.48% | -30.1% |
Q2 2021 | $36,560 | +117.6% | 225,803 | +7.8% | 0.68% | +91.3% |
Q1 2021 | $16,805 | +152.9% | 209,389 | +71.4% | 0.36% | +138.9% |
Q4 2020 | $6,645 | +351.4% | 122,143 | +65.0% | 0.15% | +198.0% |
Q3 2020 | $1,472 | -8.2% | 74,034 | -3.0% | 0.05% | -13.8% |
Q2 2020 | $1,604 | +120.9% | 76,305 | +28.6% | 0.06% | +48.7% |
Q1 2020 | $726 | -17.7% | 59,342 | -1.3% | 0.04% | -4.9% |
Q4 2019 | $882 | +10.7% | 60,107 | +0.7% | 0.04% | -6.8% |
Q3 2019 | $797 | -11.7% | 59,691 | +8.2% | 0.04% | -2.2% |
Q2 2019 | $903 | -6.8% | 55,163 | -2.8% | 0.04% | -13.5% |
Q1 2019 | $969 | +16.7% | 56,760 | -6.7% | 0.05% | -11.9% |
Q4 2018 | $830 | -64.8% | 60,834 | -26.1% | 0.06% | -53.9% |
Q3 2018 | $2,357 | -28.6% | 82,359 | -31.7% | 0.13% | -35.7% |
Q2 2018 | $3,301 | +41.7% | 120,645 | +9.2% | 0.20% | +18.5% |
Q1 2018 | $2,329 | -7.2% | 110,442 | -15.4% | 0.17% | -14.7% |
Q4 2017 | $2,510 | -64.7% | 130,608 | -54.4% | 0.20% | -66.8% |
Q3 2017 | $7,111 | +66.2% | 286,144 | +7.0% | 0.59% | +50.5% |
Q2 2017 | $4,278 | – | 267,360 | – | 0.39% | – |
Download |